Canada \u00b7 BC coverage
Is Wegovy covered in BC? BC PharmaCare, explained.
The short answer: no. BC PharmaCare lists Wegovy as a non-benefit, in a coverage decision dated December 18, 2025. Ozempic, which is the same ingredient for type 2 diabetes, is covered with Special Authority. Here is what the decision says, how the two differ, and where generic Wegovy stands.
Checked against Health Canada's Drug Product Database on October 15, 2026, and BC PharmaCare's Wegovy decision and June 2026 newsletter, read November 11, 2026.
Looking for Ozempic instead? Is Ozempic covered in BC?
What BC's Wegovy decision says
- Decision: non-benefit, dated December 18, 2025.
- What was reviewed: a resubmission for chronic weight management in adults with a BMI of 27 kg/m2 or more and established cardiovascular disease (prior heart attack, stroke or peripheral artery disease).
- Expert advice: BC's Drug Benefit Council met on August 11, 2025. Canada's Drug Agency had recommended coverage for that group only with a price reduction, finding Wegovy was not good value at the public list price.
- Evidence noted: in the SELECT trial, Wegovy reduced major cardiovascular events against placebo in people with a BMI of 27 or more and existing heart disease, with no benefit shown on cardiovascular death. BC noted uncertainty about long-term weight and heart benefit.
- Why it ended: Novo Nordisk told the pan-Canadian Pharmaceutical Alliance it would no longer seek public coverage of Wegovy in Canada, and the talks closed without agreement on December 1, 2025.
- What could change it: the Ministry said it will review manufacturer submissions for generic semaglutide, for all approved uses, once they are on the market.
Wegovy vs Ozempic coverage in BC
| Ozempic and generics | Wegovy | |
|---|---|---|
| Ingredient | Semaglutide | Semaglutide |
| Canadian indication | Type 2 diabetes | Chronic weight management; heart-risk reduction |
| BC PharmaCare | Covered with Special Authority for type 2 diabetes after metformin | Non-benefit (December 18, 2025) |
| Generic | Apotex and Dr. Reddy's, listed June 15, 2026 | Sevmia (Apotex): approved June 2026, not marketed as of November 11, 2026 |
| Covered for weight loss? | No | No |
Sources: Wegovy decision, June 2026 PharmaCare newsletter, Drug Product Database (Sevmia DIN 02569582). If your medicines go through Fair PharmaCare, you may still pay part of the cost until you reach your deductible or family maximum.
Options people ask about
- Private plans: some cover Wegovy, often with prior authorization. Ask your insurer.
- Generic Wegovy: track its status on generic semaglutide in Canada.
- Unauthorized “research” semaglutide: not a legal shortcut. Health Canada's April 2026 advisory warns against it.
What semaglutide users report
- 49 published anonymous semaglutide confessions; 7 mention at least one side effect.
- 19 mention Ozempic, Wegovy or Rybelsus by name.
- Among confessions that state a weight change in pounds, the median reported is 51 lb. Self-reported, unverified.
Most-mentioned side effects (share of semaglutide confessions):
- Burping: 6.1% (3)
- Vomiting: 6.1% (3)
- Anxiety or panic: 4.1% (2)
- Nausea: 4.1% (2)
- Constipation: 2% (1)
Counts are phrase mentions in anonymous accounts, not diagnoses or clinical rates. Full breakdown and methodology: Semaglutide hub.
By province and city
Related
Frequently asked questions
- Is Wegovy covered by BC PharmaCare?
- No. BC PharmaCare made Wegovy (semaglutide for chronic weight management) a non-benefit in a coverage decision dated December 18, 2025.
- Why doesn't BC PharmaCare cover Wegovy?
- BC's decision follows Canada's Drug Agency, which recommended coverage only for adults with a BMI of 27 or more and established cardiovascular disease, and only with a price reduction. Novo Nordisk told the pan-Canadian Pharmaceutical Alliance it would no longer seek public coverage, and those negotiations ended without agreement on December 1, 2025.
- Does BC PharmaCare cover Ozempic?
- Yes, for type 2 diabetes only. Ozempic and the Apotex and Dr. Reddy's generic semaglutide injections are covered through a prescriber's Special Authority request showing the person meets the clinical criteria. They are not covered for weight loss.
- Is generic Wegovy (Sevmia) covered in BC?
- Not yet. Health Canada authorized Sevmia, Apotex's generic semaglutide for weight management, in June 2026, but on November 11, 2026 the Drug Product Database still listed it as approved and not marketed. BC said it will review generic semaglutide submissions for all approved uses once they are on the market.
- Can a private plan in BC cover Wegovy?
- Some employer and individual plans cover Wegovy, often with prior authorization. Ask your insurer, or ask a pharmacist to run a test claim.
- Does this page recommend a clinic, product or dose?
- No. We don't list clinics, sellers, prices or doses, and nothing here is medical advice. Talk to a licensed BC prescriber or pharmacist.
Sources
Last reviewed November 11, 2026. How we source pages: editorial policy.
- BC PharmaCare drug coverage decision: semaglutide (Wegovy), December 18, 2025 (gov.bc.ca)
- PharmaCare Newsletter, June 2026: generic semaglutide listing (gov.bc.ca)
- BC PharmaCare Special Authority (gov.bc.ca)
- Health Canada: first generic semaglutide for weight loss, June 2026 (canada.ca)
- Drug Product Database (health-products.canada.ca)
General information only — not medical, legal or regulatory advice. Peptide Confessions does not sell, source or recommend any product or vendor, and nothing here is dosing guidance. Speak with a licensed Canadian healthcare professional or pharmacist about any medication. Editorial process →